[1]
Y. Su, P. Hu, S.-H. Lee, and P. J. Sinko, “Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan”, J Pharm Pharm Sci, vol. 10, no. 4, pp. 519–536, Oct. 2007.